Gain of OGP, an Estrogen-Regulated Oviduct-Specific Glycoprotein, Is Associated with the Development of Endometrial Hyperplasia and Endometrial Cancer
Michelle M.M. Woo(University of British Columbia), Nelly Auersperg(University of Central Florida), Anthony M. Magliocco(Cancer Prevention Institute of California), Harold G. Verhage(University of Illinois Urbana-Champaign), C. Blake Gilks(Fox Chase Cancer Center), Peter C. K. Leung(University of British Columbia Hospital), Abdulmohsen Alkushi(Vancouver Hospital and Health Sciences Centre)
Cited by 18
Related Papers
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
|Endocrine Reviews|2001|999
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary
|New England Journal of Medicine|2009|775
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
|Nature Medicine|2004|517